Caribou Biosciences (CRBU) EBITDA Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37,991.00 |
| Dec 31, 2025 | 57,905.00 |
| Sep 30, 2025 | 78,227.00 |
| Jun 30, 2025 | -32,987.00 |
| Mar 31, 2025 | 3,111.00 |
| Dec 31, 2024 | -7,553.00 |
| Sep 30, 2024 | -57,073.00 |
| Jun 30, 2024 | 62,390.00 |
| Mar 31, 2024 | -77,069.00 |
| Dec 31, 2023 | -89,976.00 |
| Sep 30, 2023 | 75,532.00 |
| Jun 30, 2023 | -1,864.00 |
| Mar 31, 2023 | -6,129.00 |
| Dec 31, 2022 | 10,349.00 |
| Sep 30, 2022 | -17,190.00 |
| Jun 30, 2022 | 10,373.00 |
| Mar 31, 2022 | -2,493.00 |
| Dec 31, 2021 | -20,001.00 |
| Sep 30, 2021 | 44,220.00 |
| Jun 30, 2021 | -13,988.00 |
| Mar 31, 2021 | 71,614.00 |
| Dec 31, 2020 | -85,894.00 |
| Sep 30, 2020 | -66,030.00 |
| Jun 30, 2020 | 58,651.00 |